A series of NN703 analogues with lysine mimetics combined with naphthyl- or
biphenylalanine in the core has been prepared and tested in vitro in a rat
pituitary cell based assay and subsequently in vivo in pigs in a single do
se at 50 nmol/kg. Reintroduction of certain pharmacophores in the C-termina
l of NN703. which were originally removed during optimisation for oral bioa
vailability, led to unexpectedly potent compounds in vitro as well as in vi
vo. (C) 2001 Elsevier Science Ltd. All rights reserved.